Hiperaldosteronismo primario: puntos de corte del cociente aldosterona/renina

Endocrinologia, Diabetes y Nutricion - Tập 66 - Trang 361-367 - 2019
María Laura Eugenio Russmann1, Laura Delfino1, Fabiana Fierro1, Silvina Santoro1, Mariana Peréz2, Gustavo Caruso2, Patricia Glikman1, Alicia Gauna1, Susana Lupi1
1Servicio de Endocrinología, Hospital José María Ramos Mejía, Ciudad de Buenos Aires, Argentina
2Servicio de Hipertensión Arterial, Hospital José María Ramos Mejía, Ciudad de Buenos Aires, Argentina

Tài liệu tham khảo

Seufert, 2009, Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism?: Results of the German Conn's, J Clin Endocrinol Metab., 94, 1125, 10.1210/jc.2008-2116 Funder, 2016, The management of primary aldosteronism: Case detection diagnosis, and treatment: An Endocrine Society Clinical Practice Guideline, J Clin Endocrinol Metab., 101, 1889, 10.1210/jc.2015-4061 Fierro, 2013, Medición de la concentración plasmática de renina inmunoreactiva por un método automatizado y su correlación con la actividad de renina plasmatica, Rev Argent Endocrinol Metab., 50, 71 Tiu, 2005, The use of aldosterone-renin ratio as a diagnostic test for primary hyperaldosteronism and its test characteristics under different conditions of blood sampling, J Clin Endocrinol Metab., 90, 72, 10.1210/jc.2004-1149 Leal Reyna, 2015, Screening for primary aldosteronism in an argentinian population: A multicenter prospective study, Arch Endocrinol Metab., 59, 441, 10.1590/2359-3997000000075 2003, 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension, J Hypertens., 21, 1011, 10.1097/00004872-200306000-00001 Rossi, 2016, Prospective validation of an automated chemiluminescence-based assay of renin and aldosterone for the work-up of arterial hypertension, Clin Chem Lab Med., 54, 1441, 10.1515/cclm-2015-1094 Rossi, 2007, Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma, J Hypertens., 25, 1433, 10.1097/HJH.0b013e328126856e Funder, 2008, Case detection diagnosis and treatment of patients with primary aldosteronism: An Endocrine Society Clinical Practice Guideline, J Clin Endocrinol Metab., 93, 3266, 10.1210/jc.2008-0104 Wu, 2017, Case detection and diagnosis of primary aldosteronism — The consensus of Taiwan Society of Aldosteronism, J Formos Med Assoc., 116, 993, 10.1016/j.jfma.2017.06.004 Nishikawa, 2011, Guidelines for the diagnosis and treatment of primary aldosteronism — The Japan Endocrine Society 2009, Endocr J., 58, 711, 10.1507/endocrj.EJ11-0133 Rossi, 2006, A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients, J Am Coll Cardiol., 48, 2293, 10.1016/j.jacc.2006.07.059 Stowasser, 2014, Aldosterone excess and resistant hypertension: Investigation and treatment, Curr Hypertens Rep., 16, 439, 10.1007/s11906-014-0439-7 Ahmed, 2011, Are women at risk of false-positive primary aldosteronism screening and unnecessary suppression testing than the men?, J Clin Endocrinol Metab., 96, 340, 10.1210/jc.2010-1355 Unger, 2004, Comparison of active renin concentration and plasma renin activity for the diagnosis of primary hyperaldosteronism in patients with an adrenal mass, Eur J Endocrinol., 150, 517, 10.1530/eje.0.1500517 Glinicki, 2015, The ratios of aldosterone /plasma renin activity (ARR) versus aldosterone /direct renin concentration (ADRR), J Renin Angiotensin Aldosterone Syst., 16, 1298, 10.1177/1470320313519487 Ferrari, 2004, Active renin versus plasma renin activity to define aldosterone-to-renin ratio for primary aldosteronism, J Hypertens., 22, 377, 10.1097/00004872-200402000-00023